PEPTOMYC
Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years. Currently, cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by... 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance. Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
PEPTOMYC
Social Links:
Industry:
Biotechnology Health Care Wellness
Founded:
2014-12-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.peptomyc.com
Total Employee:
11+
Status:
Active
Total Funding:
22.79 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics WordPress Google Universal Analytics Font Awesome Cloudflare JS CDN JS WordPress 6.0
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Employees Featured
Founder
Investors List
Healthequity
Healthequity investment in Venture Round - Peptomyc
Alta Life Sciences
Alta Life Sciences investment in Venture Round - Peptomyc
CDTI
CDTI investment in Venture Round - Peptomyc
Alta Life Sciences
Alta Life Sciences investment in Venture Round - Peptomyc
Aurora Science
Aurora Science investment in Venture Round - Peptomyc
Healthequity
Healthequity investment in Venture Round - Peptomyc
Centre for the Development of Industrial Technology (CDTI)
Centre for the Development of Industrial Technology (CDTI) investment in Venture Round - Peptomyc
Horizon 2020
Horizon 2020 investment in Grant - Peptomyc
Alta Life Sciences
Alta Life Sciences investment in Series A - Peptomyc
Neotec Capital Riesgo
Neotec Capital Riesgo investment in Grant - Peptomyc
Official Site Inspections
http://www.peptomyc.com Semrush global rank: 8.54 M Semrush visits lastest month: 295
- Host name: panel2.adsystems.cloud
- IP address: 89.40.80.3
- Location: Romania
- Latitude: 45.9968
- Longitude: 24.997
- Timezone: Europe/Bucharest